The Westaim Corp. $0.26 - Toronto symbol WED

THE WESTAIM CORP. $0.26 (Toronto symbol WED; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 94.0 million; Market cap: $24.4 million; SI Rating: Speculative) owns 74.5% of Nucryst Pharmaceuticals Corp. (Toronto symbol NCS), which makes medical products that prevent infection in burns and wounds. Based on current prices, this investment is worth $0.23 per Westaim share. A new development deal with UK-based Smith & Nephew plc should expand Nucryst’s earnings in 2008 and beyond. Westaim itself is still debt free, and had cash of $0.33 a share at December 31, 2007. Westaim is still a hold, but only for highly aggressive investors.

A professional investment analyst for more than 30 years, Pat has developed a stock-selection technique that has proven reliable in both bull and bear markets. His proprietary ValuVesting System™ focuses on stocks that provide exceptional quality at relatively low prices. Many savvy investors and industry leaders consider it the most powerful stock-picking method ever created.